Australia markets closed

GlaxoSmithKline plc (GLAXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
19.27-0.17 (-0.90%)
At close: 3:57PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close19.44
Bid0.00 x 0
Ask0.00 x 0
Day's range19.27 - 19.27
52-week range16.50 - 21.51
Avg. volume56,946
Market cap97.236B
Beta (5Y monthly)0.39
PE ratio (TTM)16.06
Earnings dateN/A
Forward dividend & yield1.10 (5.63%)
Ex-dividend date19 Aug 2021
1y target estN/A
  • Editor's pick
    Yahoo Finance Video

    Pfizer says vaccine is 90.7% effective in kids aged 5 to 11: BBG

    Dr. Calvin Sun, The Monsoon Diaries Founder & CEO, Clinical Assistant Professor and Attending Physician in Emergency Medicine in NYC, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.

  • Bloomberg

    23andMe Expands Into Telehealth Care With Lemonaid Purchase

    (Bloomberg) -- Consumer DNA testing giant 23andMe Holding Co. agreed to purchase telehealth upstart and drug-delivery service Lemonaid Health Inc. in a bid to make its personalized genetics approach part of patients’ primary care. Most Read from BloombergThe Top Money Maker at Deutsche Bank Reaps Billions From SingaporeWhy Americans and Britons Are Rushing to Buy Idyllic Homes in ItalyCities' Answer to Sprawl? Go Wild.Forget Palm Springs—Santa Fe Is the New Mecca for Modern ArchitectureOne of Ca

  • Motley Fool

    Why 23andMe Stock Has Jumped 16% So Far This Week

    What happened Shares of the genetic-testing company 23andMe (NASDAQ: ME) gained another 16% through Thursday's close this week, according to data from S&P Global Market Intelligence. The biotech's stock is now up by more than 34% over the past two weeks.